Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 22 Results

Title
Intervention Indication Therapeutic Area Year Actions
Atezolizumab (Tecentriq) and Cobimetinib (Cotellic) for advanced/metastatic colorectal cancer - third line Atezolizumab (Tecentriq; MPDL3280A) , Cobimetinib (Cotellic; GDC-0973; cobimetinib hemifumarate) Colorectal cancer Gastrointestinal Cancer , Oncology 2017 View  |  Download
Belzutifan for von Hippel-Lindau disease-associated clear cell renal cell carcinoma – first line Belzutifan (PT2977; MK-6482) Renal cell carcinoma (RCC) Genetic Disorders , Oncology , Renal Cancer 2021 View  |  Download
Cabozantinib with atezolizumab for treating metastatic castration-resistant prostate cancer after one novel hormonal therapy Atezolizumab (Tecentriq; MPDL3280A) , Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184) Prostate cancer Haematological Cancer and Lymphomas , Oncology 2023 View  |  Download
Encorafenib in combination with binimetinib and cetuximab for BRAF V600E mutant metastatic colorectal cancer Binimetinib (MEK162; MEK-162; ARRY-162) , Cetuximab (Erbitux; STI-001) , Encorafenib (LGX818) Colorectal cancer Gastrointestinal Cancer , Oncology 2019 View  |  Download
Entrectinib for the Treatment of NTRK-fusion Positive Solid Tumours in Adult and Paediatric Patients Entrectinib (RXDX-101) Solid tumours Haematological Cancer and Lymphomas , Oncology 2018 View  |  Download
Erdafitinib for treating advanced solid tumours with an FGFR mutation in people aged 6 years and older Erdafitinib (JNJ-42756493; BALVERSA) Solid tumours Haematological Cancer and Lymphomas , Oncology 2021 View  |  Download
Favezelimab-pembrolizumab for treating metastatic PD-L1 positive colorectal cancer Favezelimab-pembrolizumab Colorectal cancer Gastrointestinal Cancer , Oncology 2023 View  |  Download
Fruquintinib for treating refractory metastatic colorectal cancer Fruquintinib (Elunate; TAK113; HMPL013) Colorectal cancer Gastrointestinal Cancer , Oncology 2023 View  |  Download
Futibatinib for treating cholangiocarcinoma with FGFR2 gene rearrangements Futibatinib Cholangiocarcinoma Haematological Cancer and Lymphomas , Oncology 2023 View  |  Download
Glucarpidase for methotrexate toxicity Glucarpidase (Voraxaze) Methotrexate toxicity during cancer therapy Oncology , Toxicology 2022 View  |  Download
1 2 3
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications